mesomelic dwarfism, Nievergelt type

disease
On this page

Also known as mesomelic dwarfism Nievergelt typeNievergelt syndromeradioulnar synostosis and a typical rhomboid shape of the tibia and fibula

Summary

mesomelic dwarfism, Nievergelt type (MONDO:0008098) is a disease. A subtype of mesomelic dysplasia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 26

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families19WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

26 HPO clinical features (Orphanet curated; top 26 by frequency):

HPO IDTermFrequency
HP:0001376Limitation of joint mobilityVery frequent (80-99%)
HP:0002857Genu valgumVery frequent (80-99%)
HP:0002974Radioulnar synostosisVery frequent (80-99%)
HP:0002983MicromeliaVery frequent (80-99%)
HP:0002991Abnormal fibula morphologyVery frequent (80-99%)
HP:0002992Abnormality of tibia morphologyVery frequent (80-99%)
HP:0003027MesomeliaVery frequent (80-99%)
HP:0003042Elbow dislocationVery frequent (80-99%)
HP:0006501Aplasia/Hypoplasia of the radiusVery frequent (80-99%)
HP:0008368Tarsal synostosisVery frequent (80-99%)
HP:0008845Mesomelic short statureVery frequent (80-99%)
HP:0010781Skin dimpleVery frequent (80-99%)
HP:0040071Abnormal morphology of ulnaVery frequent (80-99%)
HP:0100490Camptodactyly of fingerVery frequent (80-99%)
HP:0000248BrachycephalyOccasional (5-29%)
HP:0000268DolichocephalyOccasional (5-29%)
HP:0000486StrabismusOccasional (5-29%)
HP:0000960Sacral dimpleOccasional (5-29%)
HP:0001249Intellectual disabilityOccasional (5-29%)
HP:0002650ScoliosisOccasional (5-29%)
HP:0002970Genu varumOccasional (5-29%)
HP:0003019Abnormality of the wristOccasional (5-29%)
HP:0004209Clinodactyly of the 5th fingerOccasional (5-29%)
HP:0006101Finger syndactylyOccasional (5-29%)
HP:0007598Bilateral single transverse palmar creasesOccasional (5-29%)
HP:0100729Large faceOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namemesomelic dwarfism, Nievergelt type
Mondo IDMONDO:0008098
MeSHC536120
OMIM163400
Orphanet2633
ICD-112034257092
SNOMED CT33979003
UMLSC0432231
MedGen98478
GARD0003554
Is cancer (heuristic)no

Also known as: mesomelic dwarfism Nievergelt type · Nievergelt syndrome · radioulnar synostosis and a typical rhomboid shape of the tibia and fibula

Disease family

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorderskeletal system disorderbone disorderbone development diseaseosteochondrodysplasia › mesomelic dysplasia › mesomelic dwarfism, Nievergelt type

Related subtypes (5): mesomelic dysplasia, Kantaputra type, mesomelic dwarfism, Reinhardt-Pfeiffer type, upper limb mesomelic dysplasia, Langer mesomelic dysplasia, mesomelic dysplasia, Savarirayan type

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.